chitosan has been researched along with beta-lapachone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conde, I; Espuelas, S; Font, M; Irache, JM; Larrea, E; Moreno, E; Sanmartín, C; Schwartz, J | 1 |
| Huang, QF; Li, YH; Liao, JX; Wang, GH; Zhang, DW | 1 |
2 other study(ies) available for chitosan and beta-lapachone
| Article | Year |
|---|---|
Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
Topics: Administration, Topical; Animals; Antiparasitic Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Lecithins; Leishmania major; Leishmaniasis, Cutaneous; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Skin | 2015 |
Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Doxorubicin; Drug Carriers; Drug Liberation; Female; Humans; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Naphthoquinones; Neoplasms; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Prodrugs; Reactive Oxygen Species; Silicon Dioxide; Tumor Burden | 2022 |